Advertisement

Topics

RiverVest Venture Management, LLC Company Profile

07:53 EST 13th December 2018 | BioPortfolio

RiverVest Venture Partners is a venture capital firm investing nationwide in emerging medical device, biopharmaceutical and other healthcare venture opportunities. With a total of more than 80 years of business and professional experience, our principals have the resources, knowledge and relationships required to create world-class life sciences companies. Headquartered in St. Louis, we capitalize on our access to the Midwest Centers of Excellence in life sciences.

Location

7733 Forsyth Boulevard, Suite 1650
St. Louis
Missouri
63105
United States of America

Contact

Phone: 314.726.6700
Fax: 314.726.6715
Email: tmelzer@rivervest.com


News Articles [404 Associated News Articles listed on BioPortfolio]

Mirum Pharmaceuticals brings in $120mm through Series A round

Mirum Pharmaceuticals (developing treatments for pediatric cholestatic liver diseases) raised $120mm through its Series A round. New Enterprise Associates led and was joined by Deerfield Management, F...

Series B brings in $17mm for Cardialen

Cardialen Inc. (developing a low-energy implantable defibrillation therapy to gently restore normal heart rhythm) raised $17mm in its Series B financing led by RiverVest Venture Partners, which was jo...

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies

Houston—OncoResponse, a Seattle biotech startup formed jointly with the University of Texas M.D. Anderson Cancer Center in Houston, announced Tuesday it has raised a $40 million Series B round o...

Immunotherapy firm OncoResponse secures $40m series B financing

Participants in the round, which was led by RiverVest Venture Partners, included new investors Qatar Investment Authority (QIA) and Redmile Group, and existing investors Alexandria Venture Investments...

OncoResponse Raises $40 Million in Series B Financing

-- Adds RiverVest Venture Partners, Qatar Investment Authority and Redmile Group to List of Financial Backers -- -- Proceeds Will Advance Growing Portfolio of Therapeutic...

Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy

Cardialen is developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm Cardialen, Inc., a medical device company developin...

28-7 Therapeutics Raises $65 Million to Advance Tumor Suppressor Research

Twentyeight-Seven Therapeutics (28-7), announced it had completed a $65 million Series A financing. It was co-led by founding investor MPM Capital and Novartis Venture Fund. Joining them were Johnson ...

PubMed Articles [1798 Associated PubMed Articles listed on BioPortfolio]

A Misguided Venture: Presidential Fitness and the Duty to Warn.

Commentary on "A Misguided Venture: Presidential Fitness and the Duty to Warn".

Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.

Grant Funding Needs Parallel the Start-Up Venture: An Analogy for Translational Research Success.

This editorial offers some ways to think about how best to position a research group for funding, by examining the parallels between what is needed for translational grants versus industry start-ups.

Supporting self-management in palliative care throughout the cancer care trajectory.

Despite increased survivorship and the subsequent need for chronic management of cancer, the association of self-management and palliative care is still emerging within cancer care. Routine and timely...

Clinical Trials [2605 Associated Clinical Trials listed on BioPortfolio]

Quest Sound Recover (SR2) vs. Venture SR2

Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform. To investigate the improvements of this feature is compared on a new and older hearing...

Hepatitis C Self-Management

The objective of this study is to compare the efficacy of a 6-session hepatitis C self-management workshop to a hepatitis C self-management self-study program. Both interventions are desig...

Contingency Management Treatment Duration

310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatmen...

Allo - Cancer - Thrombosis

Management of venous thromboembolism (VTE) in patients with cancer is complex and require the intervention of many specialized health professionals, in hospital but also at home and during...

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagon...

Companies [2068 Associated Companies listed on BioPortfolio]

RiverVest Venture Partners

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder va...

RiverVest Venture Management, LLC

RiverVest Venture Partners is a venture capital firm investing nationwide in emerging medical device, biopharmaceutical and other healthcare venture opportunities. With a total of more than 80 years o...

Venture Verde

Venture Verde is a real estate, land and water management company and a subsidiary of BLMG Holdings, LLC (BLMG). Venture Verde consults and develops sustainable turnkey fac...

Origo Management

Origo Management provides specialized consulting services to the private equity and venture capital industry. Our clients include players from all stages of the private equity and venture capital valu...

Advent Venture Partners

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Science...

More Information about "RiverVest Venture Management, LLC" on BioPortfolio

We have published hundreds of RiverVest Venture Management, LLC news stories on BioPortfolio along with dozens of RiverVest Venture Management, LLC Clinical Trials and PubMed Articles about RiverVest Venture Management, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RiverVest Venture Management, LLC Companies in our database. You can also find out about relevant RiverVest Venture Management, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record